New stock news: Tian and He Xing submit the Hong Kong Exchange.
According to the Hong Kong Stock Exchange disclosed on January 30th, Beijing Tiandi Huixing Technology Co., Ltd. (hereinafter referred to as "Tiandi Huixing") has submitted its application for listing on the main board of the Hong Kong Stock Exchange, with Citic Securities International and Orient Securities International as its joint sponsors.
According to the disclosure by the Hong Kong Stock Exchange on January 30, Beijing Tiandi Hexing Technology Co., Ltd. (referred to as: Tiandi Hexing) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with China Securities Co., Ltd. International and Orient International acting as its joint sponsors. The prospectus shows that Tiandi Hexing is a well-known provider of industrial network security and energy digitalization comprehensive solutions in China. Tiandi Hexing uses AI-driven technology to enhance the security protection capabilities of enterprise users in various industrial scenarios. In addition to providing comprehensive industrial network security solutions, the company also provides digital solutions for energy sector enterprise users, with core capabilities such as real-time status perception, early warning of risks, and process optimization. According to Frost & Sullivan data, by market share, the company is expected to rank first in the Chinese industrial network security market by 2024, with an overall market share of approximately 6.7%, especially in the energy sector of the Chinese industrial network security market with a market share of approximately 8.4%.
Related Articles

Guangzhou Great Power Energy and Technology (300438.SZ) submitted an application for the issuance and listing of H shares to the Hong Kong Stock Exchange, and published the application materials.

Wanbang Pharmaceutical Holding Group (002082.SZ): The phase II/III clinical trial of Shishanjian Jia controlled release tablets has enrolled 100 subjects.

Nio delivered 27,182 vehicles in January, a year-on-year increase of 96.1%.
Guangzhou Great Power Energy and Technology (300438.SZ) submitted an application for the issuance and listing of H shares to the Hong Kong Stock Exchange, and published the application materials.

Wanbang Pharmaceutical Holding Group (002082.SZ): The phase II/III clinical trial of Shishanjian Jia controlled release tablets has enrolled 100 subjects.

Nio delivered 27,182 vehicles in January, a year-on-year increase of 96.1%.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


